Journal article
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study
- Abstract:
-
Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify transcriptomic immune response biomarker signatures induced by vaccination and associated signatures with its immunogenicity and reactogenicity to better understand the potential mechanisms of action of the vaccine. Methods 354 healthy adult volunteer...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
- Publisher copy:
- 10.1016/S2666-5247(21)00235-4
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet Microbe More from this journal
- Volume:
- 3
- Issue:
- 2
- Pages:
- e113-e123
- Publication date:
- 2021-12-06
- DOI:
- EISSN:
-
2666-5247
- Language:
-
English
- Keywords:
- Pubs id:
-
1257047
- Local pid:
-
pubs:1257047
- Deposit date:
-
2022-06-10
- ARK identifier:
Terms of use
- Copyright holder:
- Vianello et al.
- Copyright date:
- 2022
- Rights statement:
- © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record